浙江聯合投資(08366.HK):接獲復牌指引 繼續停牌
格隆匯11月1日丨浙江聯合投資(08366.HK)公吿,於2021年10月22日,公司接獲聯交所函件,當中(其中包括)聯交所載列以下復牌指引:(a)刊發GEM上市規則規定所有尚未刊發財務業績及處理任何審核保留意見;(b)證明對於管理層誠信及任何對公司管理及營運具有重大影響力人士誠信均沒有合理監管憂慮(其將會對投資者帶來風險及損害市場信心);(c)證明公司遵守GEM規則第17.26條;及(d)知會市場所有重大資料,以供公司股東及投資者評估公司狀況。
於股份獲准恢復買賣前,公司必須補救導致其暫停買賣事項,並完全遵守GEM上市規則至聯交所信納。
繼續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.